- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05726045
Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation
Increasing the Smoking Cessation Success Rate by Enhancing Improvement of Self-control Through Sleep-amplified Memory Consolidation
The goal of this subproject is to examine the hypothesized improvement of treatment with chess-based training and sleep enhancement, both together and on their own, in smokers.
Participants will undergo fMRI measurements, sleep monitoring. They will then be assigned to one of the four experimental groups, including high-intensity interval training with or without chess-based training.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gordon Feld, Dr.
- Phone Number: 6540 +49-621/1703
- Email: gordon.feld@zi-mannheim.de
Study Contact Backup
- Name: Sabine Vollstädt-Klein, Prof. Dr.
- Phone Number: 3912 +49-621/1703
- Email: s.vollstaedt-klein@zi-mannheim.de
Study Locations
-
-
Baden-Württemberg
-
Mannheim, Baden-Württemberg, Germany, 68159
- Recruiting
- Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
-
Contact:
- Sabine Vollstädt-Klein, Prof. Dr.
- Email: s.vollstaedt-klein@zi-mannheim.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- severe tobacco use disorder (TUD) according to DSM-5
- sufficient ability to communicate with investigators and answer questions in both written and verbal format
- ability to provide fully informed consent and to use self-rating scales
- right-handedness
- HIIT can be performed without the risk of side effect (medical sports check)
Exclusion Criteria:
- severe internal, neurological, and/or psychiatric comorbidities; other Axis I mental disorders other than TUD according to ICD-10 and DSM 5 (except for mild depression, i.e. F32.0, adjustment disorder and specific phobias) in the last 12 months
- history of brain injury
- severe physical diseases
- common exclusion criteria for MRI (e.g. metal, claustrophobia)
- positive drug screening (opioids, benzodiazepines, barbiturates, cocaine, amphetamines)
- psychotropic medication within the last 14 days
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: HIIT morning
High-intensity interval training (HIIT) in the morning
|
Each subject will receive a standard SCP as group treatment once a week (1h) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer, 2004), and will be carried out by a qualified therapist.
|
|
Experimental: HIIT evening
High-intensity interval training (HIIT) in the evening
|
Each subject will receive a standard SCP as group treatment once a week (1h) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer, 2004), and will be carried out by a qualified therapist.
The high-intensity interval training will be delivered through an app environment with several choices of exercise, two times per week over six weeks. The training will include a 5-minutes warm-up and cool down phase. In between, participants will perform four 4-minutes blocks of exercise at high intensity, interspersed with three 3-minute blocks of low intensity (total of 35 minutes exercise). |
|
Active Comparator: HIIT morning + CRT
High-intensity interval training (HIIT) in the morning + cognitive remediation treatment (CRT)
|
Each subject will receive a standard SCP as group treatment once a week (1h) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer, 2004), and will be carried out by a qualified therapist.
The cognitive remediation treatment (CRT) employs a chess-based battery of tasks (delivered through an app-based online tool), two times per week over six weeks (60min duration per session).
|
|
Experimental: HIIT evening + CRT
High-intensity interval training (HIIT) in the evening+ cognitive remediation treatment (CRT)
|
Each subject will receive a standard SCP as group treatment once a week (1h) over six weeks.
This group therapy is based on behavioural therapy and a psycho-educational approach (for more details see Batra & Buchkremer, 2004), and will be carried out by a qualified therapist.
The high-intensity interval training will be delivered through an app environment with several choices of exercise, two times per week over six weeks. The training will include a 5-minutes warm-up and cool down phase. In between, participants will perform four 4-minutes blocks of exercise at high intensity, interspersed with three 3-minute blocks of low intensity (total of 35 minutes exercise).
The cognitive remediation treatment (CRT) employs a chess-based battery of tasks (delivered through an app-based online tool), two times per week over six weeks (60min duration per session).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time until first severe relapse
Time Frame: timepoint 3: follow-up 3 months after end of SCP
|
days until the first severe smoking relapse after treatment
|
timepoint 3: follow-up 3 months after end of SCP
|
|
Percentage of abstinent days
Time Frame: timepoint 3: follow-up 3 months after end of SCP
|
Percentage of abstinent days in the 3 months after treatment
|
timepoint 3: follow-up 3 months after end of SCP
|
|
Change in smoking urges
Time Frame: 2 time points: before and after 6 weeks SCP
|
questionnaire of smoking urges (QSU, Müller et al. 2001)
|
2 time points: before and after 6 weeks SCP
|
|
Change in neural measures of response inhibition
Time Frame: 2 time points: before and after 6 weeks SCP
|
SST fMRI task (Gan et al., 2014)
|
2 time points: before and after 6 weeks SCP
|
|
Change in neural measures of working memory
Time Frame: 2 time points: before and after 6 weeks SCP
|
Nback fMRI task (Charlet et al., 2014)
|
2 time points: before and after 6 weeks SCP
|
|
Change in neural functional connectivity in the salience network
Time Frame: 2 time points: before and after 6 weeks SCP
|
resting state connectivity to seed region right anterior insula
|
2 time points: before and after 6 weeks SCP
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gordon Feld, Dr., Central Institute of Mental Health, Mannheim
- Principal Investigator: Karen Ersche, Prof. Dr., Central Institute of Mental Health, Mannheim
- Principal Investigator: Sabine Vollstädt-Klein, Prof. Dr., Central Institute of Mental Health, Mannheim
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TRR265 C01-P2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Disorder
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Nicotine Dependence | Tobacco Dependence | Smoking, Tobacco | Nicotine Use Disorder | Nicotine Dependence, Cigarettes | Smoking, Cigarette | Nicotine Dependence Tobacco Product | Tobacco; Use, Rehabilitation | Smoking (Tobacco) Addiction and other conditionsUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Cessation | Tobacco Dependence | Tobacco ChewingUnited States
-
Harvard School of Public Health (HSPH)Beacon Communities; The Community BuildersEnrolling by invitationTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Second Hand Tobacco SmokeUnited States
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco DependenceUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramCompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institute on Minority Health...CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation | Tobacco Dependence | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Centre for Addiction and Mental HealthCanadian Cancer Society (CCS)RecruitingSmoking Cessation | Tobacco Smoking | Substance Use Disorders | Nicotine Dependence | Nicotine Use DisorderCanada
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA)CompletedSchizophrenia | Schizoaffective Disorder | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use CessationUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
Clinical Trials on Standard smoking cessation program (SCP)
-
Central Institute of Mental Health, MannheimCompleted
-
Masonic Cancer Center, University of MinnesotaUniversity of MinnesotaRecruiting
-
Kimber Richter, PhD, MPH, MANational Heart, Lung, and Blood Institute (NHLBI)CompletedSmokingUnited States
-
University of SalernoNot yet recruitingSmoking Cessation | Smoking Behaviors | Smoking Dependence | Smoking Abstinence | Smoking Cessation Intervention | Smoking (Tobacco) Addiction | Smoking E-cigarette | Smoking Addiction | Smoking ( Cigarette)
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Boston Medical CenterCompleted
-
China Medical University HospitalUnknown
-
University of MilanEuropean Institute of Oncology; Fondazione Umberto VeronesiUnknown
-
National Institute on Aging (NIA)Completed
-
National Institute of Neurological Disorders and...CompletedSmoking | ObesityUnited States